Chronic kidney disease affects approximately 850 million people globally, with hyperkalemia representing a disproportionately high burden in this population¹. While hyperkalemia occurs in only 2-3% of ...

Hyperkalemia is a potentially life-threatening side effect of RAASi use. Individuals with heart failure are particularly susceptible because heart failure itself can cause hyperkalemia. “Several ...

Investigators sought to distinguish the underlying cause of hyperkalemia after solid organ transplantation, whether from medications or organ dysfunction. Among solid organ transplant recipients, ...

A 63-year-old asymptomatic man has had mild hyperkalemia (5.6-6.0 mEq/L) for the past six months. His physical examination and lab work are remarkable only for an elevated cholesterol level. He is a ...

Please provide your email address to receive an email when new articles are posted on . Fewer patients with hyperkalemia were prescribed renin-angiotensin-aldosterone system inhibitors for HF.

A new risk model may help identify which patients with chronic kidney disease (CKD) and diabetes are more likely to develop hyperkalemia, granting physicians more confidence in prescribing medications ...

Hyperkalemia is a common and dangerous complication of ESRD and hemodialysis. Number of hemodialysis sessions, BUN, serum sodium, serum calcium, serum phosphorous, and diabetes predict hyperkalemia ...

Please provide your email address to receive an email when new articles are posted on . Overall, 38 patients had hyperkalemia before dialysis, researchers found. A daily intake of greater than 15.33 g ...

EXTON, Penn.--(BUSINESS WIRE)--While the perceived need for new therapies for hyperkalemia is relatively low compared to a number of other conditions in nephrology, interest is high in Relypsa’s ...

SGLT2i and GLP-1RA are associated with lower risks of hyperkalemia compared with DPP4i in patients with CKD and type 2 diabetes. Hyperkalemia risks in patients with chronic kidney disease (CKD) and ...